Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | RXRA | P19793 | 2/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.48 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | LOX | P28300 | 1/20 | 0.48 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.47 |
| ▸ | PARP1 | P09874 | 1/20 | 0.41 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.41 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.41 |
| ▸ | TYMS | P04818 | 1/20 | 0.39 |
| ▸ | MYC | P01106 | 1/20 | 0.37 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6756006 | 1.00 | LMNA (0.51) | LMNARXRAMAOBMAOALOX | |
| SCHEMBL6756002 | 1.00 | LMNA (0.51) | LMNARXRAMAOBMAOALOX | |
| SCHEMBL6785050 | 0.85 | RXRA (0.55) | LMNARXRAMAOBCYP19A1CYP11B1 | |
| SCHEMBL6785053 | 0.85 | RXRA (0.55) | LMNARXRAMAOBCYP19A1CYP11B1 | |
| SCHEMBL6785056 | 0.85 | RXRA (0.55) | LMNARXRAMAOBCYP19A1CYP11B1 | |
| SCHEMBL9390068 | 0.84 | RXRA (0.48) | LMNARXRAMAOBMAOALOX | |
| SCHEMBL6785652 | 0.84 | RXRA (0.48) | LMNARXRAMAOBMAOALOX | |
| SCHEMBL6785655 | 0.84 | RXRA (0.48) | LMNARXRAMAOBMAOALOX | |
| Hydrochloric Acid SCHEMBL6785658 | 0.84 | RXRA (0.54) | LMNARXRAMAOBCYP19A1CYP11B1 | |
| SCHEMBL7564439 | 0.81 | MAOB (0.63) | LMNARXRAMAOBMAOALOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0759025-B1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | WELLCOME FOUND (GB) | 1999-07-21 | — | — | EP | claimed |
| EP-0759025-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1997-02-26 | — | — | EP | claimed |
| WO-1995030644-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-11-16 | — | — | WO | claimed |
| WO-1994026692-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | claimed |
| US-20040116405-A1 | Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity | GLAXO GROUP LIMITED (GB) | 2004-06-17 | — | — | US | disclosed |
| EP-1358150-A1 | USE OF BICYCLIC ESTERS OR AMIDES FOR THE TREATMENT OF DISEASES RESPONSIVE TO ENHANCED POTASSIUM CHANNEL ACTIVITY | GLAXO GROUP LIMITED (GB) | 2003-11-05 | — | — | EP | disclosed |
| WO-2002062745-A1 | USE OF BICYCLIC ESTERS OR AMIDES FOR THE TREATMENT OF DISEASES RESPONSIVE TO ENHANCED POTASSIUM CHANNEL ACTIVITY | GLAXO GROUP LIMITED (GB) | 2002-08-15 | — | — | WO | disclosed |
| EP-0759025-B1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | WELLCOME FOUND (GB) | 1999-07-21 | — | — | EP | disclosed |
| US-5719186-A | CENTRAL MUSCLE RELAXANTS, ANXIOLYTIC AGENTS, ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTICONVULSANTS | GLAXO WELLCOME INC. (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0759025-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1997-02-26 | — | — | EP | disclosed |
| WO-1995030644-A1 | AMIDE DERIVATIVES AND THEIR THERAPEUTIC USE | THE WELLCOME FOUNDATION LIMITED (GB) | 1995-11-16 | — | — | WO | disclosed |